A roundup of companies announcing mergers and acquisitions.
- Stryker completes sale of OP-1 for use in orthopaedic applications to Olympus
Stryker Corp. (NYSE:SYK) closed of the previously announced sale of its OP-1 product family, which includes OP-1 Implant, OP-1 Putty, Opgenra and Osigraft, for use in orthopaedic bone applications. The transaction also includes the sale of the manufacturing facility in Lebanon, N.H.
- Genzyme completes sale of diagnostics biz to Sekisui Chemical Co.
Genzyme Corp. (NSDQ:GENZ) completed the sale of its diagnostic products business to Sekisui Chemical Co. Ltd. (TYO:4204) for $265 million in cash. Sekisui purchased substantially all of the assets of the business, including diagnostic product lines and technologies. Genzyme’s approximately 575 employees in the business were offered similar positions with Sekisui, which plans to maintain operations in each of the business’s current locations. In connection with the sale, Sekisui also entered into a supply agreement to provide Genzyme with certain enzymes needed for the production of Cerezyme (imiglucerase for injection). Genzyme also announced that it has entered into a purchase agreement under which an affiliate of International Chemical Investors Group (ICIG) will acquire Genzyme’s pharmaceutical intermediates business.
- Intrexon launches AgBio division and acquires Agarigen Inc.
Intrexon Corporation, a synthetic biology company, announced the launch of its Agricultural Biotechnology (AgBio) Division in Research Triangle Park, North Carolina and the acquisition of Agarigen, Inc., a North Carolina-based company that has developed a novel, mushroom-based expression platform for the rapid, high yield production of recombinant proteins. Matthew B. Crisp has been appointed Division President and a Senior Vice President of the company. Mr. Crisp was most recently a Managing Director of Third Security, LLC in Radford, Virginia, a globally recognized investment company led by Randal J. Kirk, Intrexon’s Chairman and CEO.
- Frazier Healthcare Announces Acquisition of Laboratory Supply Company Inc.
Frazier Healthcare, a provider of growth equity and venture capital to high growth and emerging healthcare companies, acquired Laboratory Supply Company Inc. (LABSCO). Headquartered in Louisville, Kentucky, LABSCO is the largest privately held supplier of diagnostic instrumentation and clinical laboratory products to hospitals, physician office laboratories, reference labs and other non-acute care settings in the United States. Under Frazier Healthcare’s ownership, LABSCO will continue to operate under the LABSCO name and provide services to the more than 8,000 customers currently served by the company.
- VWR International LLC acquires AMRESCO Inc.
VWR International LLC, a global distributor of laboratory supplies and services, acquired AMRESCO Inc., a manufacturer and supplier of high quality biochemicals and reagents for Molecular Biology, Life Sciences, Proteomics, Clinical and Histology areas of research and production.